Skip to main content

Multicenter Open Label Phase Ib/II Trial of Abemaciclib and Elacestrant in Patients with Brain Metastasis due to HR+/Her2- Breast Cancer

Clinical Trial Grant
Duke Scholars

Administered By

Duke Cancer Institute

Awarded By

Criterium, Inc

Start Date

December 9, 2021

End Date

December 31, 2026
 

Administered By

Duke Cancer Institute

Awarded By

Criterium, Inc

Start Date

December 9, 2021

End Date

December 31, 2026